Over 4,000 people enroll in Phase II trial of local COVID-19 vaccine
03/30/2021 08:30 PM
Over 4,000 people in Taiwan have enrolled in the second-stage clinical trial of a domestic COVID-19 vaccine, of whom around 3,700 have already received an injection, the vaccine's developer, Medigen Vaccine Biologics Corp. (MVC), announced Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares end at new high but most gains eroded
10/21/2025 04:31 PM - Culture
Taiwan's National Palace Museum celebrates centennial with 3 exhibitions
10/21/2025 04:28 PM - Society
3 batches of imported cheese blocked at border for E. coli
10/21/2025 04:15 PM - Business
U.S. dollar closes higher on Taipei forex market
10/21/2025 04:12 PM - Politics
Lai congratulates Takaichi on becoming 1st female Japanese PM
10/21/2025 03:53 PM